干细胞技术进展

干细胞技术是人类后基因组计划的一部分。随着这一技术的科研和应用的快速发展，人们开始认识到这一技术的具大诱惑。本对干细胞的概念、种类、技术原理、进行了概括，对干细胞技术应用领域、发展前景等进行了研究。     

骨髓间充质干细胞研究进展

干细胞移植是目前治疗器官损伤、神经退行性疾病研究的热点,国内外学者分别对神经干细胞、胚胎干细胞等进行了探索,渴望从中找出细胞移植领域的候选细胞,但是这些细胞大多面临着伦理、来源、免疫排斥等多方面的问题.然而,近年来发现的骨髓间充质干细胞在一定程度上弥补了这一不足.骨髓间充质干细胞凭借其多向分化潜能、强大的自我复制能力和可移植性,成为细胞移植、基因治疗中重要的候选细胞.骨髓间充质干细胞移植为器官损伤、神经退行性疾病的临床治疗带来了新的希望,本文对其生物学特性及临床应用方面做一综述.     

干细胞研究进展

由于干细胞具有自我更新和多向分化潜能的功能,使得人们用干细胞治疗多种疾病成为可能.就干细胞的研究概况、研究技术、干细胞技术的市场前景以及干细胞研究面临的问题等作一概述.     

干细胞研究国际发展态势分析

干细胞以其自我更新和多向分化的能力得到了国际社会的普遍关注,为干细胞疗法的临床应用带来了希望.该文结合文献计量方法,对干细胞以及诱导多能干细胞、胚胎干细胞和间充质干细胞等3个干细胞研究重点领域的科研现状进行了分析,总结了这些领域的发展趋势和重点研究方向,并根据分析结果,对我国干细胞领域采取的措施、今后发展的方向提出了建...     

中国干细胞研究的现状、挑战和机遇

干细胞研究是过去十年中生物医学研究中最为热门的领域之一。我国的干细胞研究取得了很大的进步,同时也遇到不少问题。本文回顾了过去几年中我国干细胞研究的发展情况,从科研投入、硬件建设、人才队伍、科研成果、公共资源、法律法规、伦理准则、知识产权等多个方面,对我国干细胞研究的现状、面临的机遇和挑战进行了思考和分析,旨在对我们的工作有一个清醒的认识,以便能更好地部署我们下一步的工作。     

我国干细胞产业发展态势及其对策研究

干细胞研究是近年来生物医学领域的最热门的研究方向之一,近年来受到世界各国的高度重视,具有巨大的社会效益和市场前景。本文针对我国干细胞产业的发展现状和可持续发展要求,对干细胞产业发展的市场需求、产业目标、技术壁垒、研发需求等进行分析,并对该产业中的共性关键技术进行凝练,包括干细胞采集及存储业务、干细胞技术研发、干细胞移植及治疗、与其他产业结合等整个产业链,研究我国干细胞产业的技术发展现状,并提出干细胞产业发展的相关对策。     

体细胞核移植技术和诱导多功能干细胞技术的研究比较

本文主要对体细胞核移植技术和诱导多功能干细胞技术的具体操作过程、两种技术当前面临的问题以及他们的应用前景进行了简要说明.     

造血干细胞的研究进展

干细胞是一类具有自我更新、高度增殖和多向分化潜能的原始细胞．造血干细胞在胚胎时期的发生、发育过程已得到进一步阐明．造血干细胞的移植已成功的应用于治疗多种血液系统和相关系统疾病．作者对造血干细胞的来源、细胞表面标志和其临床应用前景进行了综述．     

干细胞及其应用

干细胞是当今细胞生物学乃至整个生命科学的主要热点之一，从干细胞的概念、生物学特性、分类等方面对干细胞进行了阐述，同时也对干细胞在移植治疗、克隆技术及转基因技术等方面的应用作了综述。     

干细胞背后的真相

这段时间“干细胞”是一个很热的话题。作为一种治疗变异性失调的潜在特致药，干细胞受到广泛欢迎，但也引起一场政治争论。在美国，这方面的研究只取得了有限的进展。“成人干细胞和存在更多伦理问题的胚胎干细胞发挥相同的作用”这个声明成为这场政治争论的焦点。耶鲁大学医学研究者Ｄiane Krause博士是成人干细胞研究的领头人之一，Robert Harris研究了这场争论背后的实质问题。     

干细胞的研究和应用

干细胞是一类具有自我更新和多向分化潜能的细胞群体,它能长期地自我更新,在特定的条件下具有分化形成多种终末细胞的能力,不同来源的干细胞分化潜能各异。近年来干细胞的研究与应用几乎涉及到所有生命科学和生物医学领域。本文概述了干细胞的生物学特性和它的可塑性,综述了分离培养技术及其在基础研究和临床上应用的研究进展,最后,提出了问题和展望。     

Advances in the study on induced pluripotent stem cells

Recently, the study on ＂induced pluripotent stem cells＂ （iPS cells） has made a great breakthrough, and it is considered as a new milestone in the history of life science. This progress has updated our traditional concepts about pluripotency control, and provided people with a brand-new strategy for somatic cell nuclear reprogramming. In virtue of its availability and stability, this method holds great potential in both biological and clinical research. In order to introduce this rising field of study, this paper starts with an overview of the development of iPS cell establishment, describes the key steps in generating iPS cells, elaborates several relevant scientific issues, and evaluates its current restrictions and promises in future research.     

涡虫成体干细胞研究进展

干细胞研究是当代生命科学研究的重点和热点之一,涡虫因具有结构简单、再生速度快、基因与脊椎动物同源性高等特点而成为研究再生的良好动物模型.涡虫的这种再生能力与其体内具有被称为neoblasts的多能干细胞群有关.文中结合近几年的研究成果从neoblasts与涡虫的再生关系、neoblasts的分子标记及研究方法3个方面进行综述,以促进neoblasts的研究.     

神经干细胞的诱导分化

目的：探讨神经干细胞（NSCs）的诱导分化机制。方法：本文就Nscs的来源、分布、诱导分化的调控机制和因素以及其应用前景作一综述。结果：神经干细胞可从鼠、人的胚胎和成年中枢神经系统（CNS）成功分离并培养，具有自我更新和多分化潜能，经体外诱导或植入体内后均能分化为成熟神经元和神经胶质细胞。结论：神经干细胞的发现和研究的深入为神经发育研究及中枢神经功能重建提供了新的思路。     

Induced pluripotent stem cell (iPS) technology: promises and challenges

In 2006, an article published in Cell by Shinya Yamanaka took by surprise the stem cell research community. By performing systematic retroviral transduction of factors enriched in embryonic stem (ES) cells, the authors demonstrated the reprogramming of mouse fibroblasts into an ES cell-like state. These cells, baptized iPS (induced pluripotent stem) cells, were immediately recognized as a ground-breaking discovery. Subsequently, the same authors and other groups reported a similar achievement with human fibroblasts. Two years later, the number of top quality papers on iPS is astonishing, and interest in the scientific community has risen to a fever pitch. But although iPS has the potential to revolutionize Regenerative Medicine, important questions still remain unanswered. Work from multiple laboratories worldwide including ours is focused on deciphering the molecular mechanisms of iPS, and trying to improve the technique to make it suitable for the clinic. In this review article we briefly discuss the past, present and future of iPS, with emphasis on urgent issues to be solved. Supported by the National Nature Science Foundation of China (Grant Nos. 30725012, 30630039 and 90813033), Knowledge Innovation Project of Chinese Academy of Sciences (Grant No. KSCX2-YW-R-48), National Key Basic Research and Development Program of China (Grant Nos. 2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804. 2007CB947900) and Guangzhou Science and Technology Development Funds (Grant No. 2008A1-E4011)     

On the “plasticity”of adult stem cells and its application in regenerative medicine

In recent years, with the increasingly further studies on embryonic stem cells and the recognition of the biologic characteristics of adult stem cells, it has been discovered that adult stem cells have another phenomenon of “plasticity” in addition to the characteristics of strong potential for self-renewal, proliferation and multi-differentiation, which brings us the hope for regenerative medicine—renewing new organ or tissue cells to replace those damaged by injury or diseases. Although the mechanism of “plasticity” and its application in the regenerative medicine are still in doubt, thorough exploration in these subjects would open up broad prospects for the use in cell and tissue engineering in the near future.     

Akt–Oct4 regulatory circuit in pluripotent stem cells

Oct4 is mainly expressed in embryonic stem cells(ESCs),germline stem cells,and embryonal carcinoma cells(ECCs)and plays an indispensable role in maintaining the pluripotency and self-renewal of these pluripotent stem cells.Akt serine/threonine kinase,a wellestablished anti-apoptosis and cell survival factor,has also been implicated as an important regulator of stemness.Emerging evidence indicated that Oct4 is reciprocally connected to Akt via a number of routes,and moreover,a direct interaction between Oct4 and Akt has recently been revealed.These components collectively form the Akt–Oct4 regulatory circuit.In this review,we summarize our current knowledge about the Akt–Oct4 regulatory circuit in ESCs and discuss its alterations in ECCs that may underlie the tumorigenesis of pluripotent stem cells.     

诱导性多能干细胞专利技术态势分析

该文基于德温特专利数据库和中科院专利在线分析系统,利用TDA和Thomson Innovation等分析工具和平台对诱导性多能干细胞技术领域的专利进行了定量与定性的分析。此外通过绘制专利技术路线图,提出专利战略布局建议,并针对中国诱导性多能干细胞的专利技术发展特点提供对策与参考意见。